What is Ebixa 10 mg (Memantine Hydrochloride)?
Ebixa 10 mg (Memantine Hydrochloride) is a type of medicine that has been approved for the treatment of patients with moderate to severe Alzheimer’s disease. Ebixa does not treat the cause of the disease, but it allows patients maybe some longer function independently.
Treatment should be started and supervised by a doctor who has experience in the diagnosis and treatment of Alzheimer’s disease. Treatment should only be started if a caregiver is available who will regularly monitor the use of Ebixa by the patient.
Ebixa was more effective than placebo at controlling the symptoms of Alzheimer’s disease. In the study of moderately severe to severe disease, patients taking Ebixa had fewer symptoms than those taking placebo after 28 weeks, as measured on both global and functional scores. In the two studies of mild to moderate disease, patients on Ebixa had less severe symptoms after 24 weeks, as measured on the global and cognitive scores. However, when these results were considered along with those of the three additional studies, it was noted that the effect of Ebixa was smaller in patients with mild disease.
Ebixa 10 mg (Memantine Hydrochloride) Dosage Form: tablet, oral solution Indications and Usage for Namenda Namenda (memantine hydrochloride) is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Namenda Dosage and Administration The recommended starting dose of Namenda
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medicine only for the indication prescribed.
Buy Ebixa 10 mg (Memantine Hydrochloride)